Crinetics Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $25,118 | $10,734 | $6,161 | $143 |
Gross Profit | 24,964 | 10,534 | 6,161 | 143 |
EBITDA | -131,386 | -126,685 | -121,641 | -129,079 |
EBIT | -132,459 | -127,845 | -122,635 | -130,091 |
Net Income | -120,855 | -127,845 | -122,815 | -130,091 |
Net Change In Cash | 25,118 | 10,734 | 6,161 | 143 |
Free Cash Flow | -94,714 | -125,523 | -93,359 | -111,581 |
Cash | 55,498 | 114,341 | 101,536 | 110,901 |
Basic Shares | 105,560 | 104,099 | 94,057 | 94,215 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,696 | $1,039 | $4,013 | $4,737 |
Gross Profit | 6,620 | 1,039 | 4,013 | 4,737 |
EBITDA | -461,247 | -295,623 | -213,431 | -166,899 |
EBIT | -465,137 | -298,408 | -214,529 | -167,882 |
Net Income | -465,317 | -298,408 | -214,529 | -159,954 |
Net Change In Cash | 7,696 | 1,039 | 4,013 | 4,737 |
Free Cash Flow | -383,684 | -229,814 | -170,995 | -116,861 |
Cash | 101,536 | 264,545 | 54,897 | 32,671 |
Basic Shares | 94,057 | 80,783 | 58,071 | 51,982 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.14 |
2026-03-31 | -$1.23 |
2025-12-31 | -$1.29 |
2025-09-30 | -$1.38 |